In vivo potentiation of [D-Ala2]Met-enkephalin amide central effects after administration of an enkephalinase inhibitor.
D000818:Animals; D001921:Brain / Q000187:drug effects*; D004151:Dipeptides / Q000494:pharmacology*; D004357:Drug Synergism; D004723:Endorphins / Q000494:pharmacology*; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives*; D004745:Enkephalins / Q000494:pharmacology*; D008297:Male; D015260:Neprilysin; D011480:Protease Inhibitors; D051381:Rats; D011919:Rats, Inbred Strains
D004151:Dipeptides; D004723:Endorphins; D004745:Enkephalins; D011480:Protease Inhibitors; D004744:Enkephalin, Methionine; C022118:enkephalinamide-Met, Ala(2)-; C033601:phosphorylleucylphenylalanine; D015260:Neprilysin